Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,519	1,792	1,936	698	346	386
Market Cap Growth	89.36%	-7.42%	177.28%	101.66%	-10.41%	95.90%
Enterprise Value	2,080	1,675	1,684	528	219	311
Last Close Price	21.12	16.81	18.60	6.77	3.34	3.75
PE Ratio	17.92	26.68	24.80	18.30	4.70	12.50
Forward PE	15.57	14.13	14.98	13.97	8.97	9.00
PS Ratio	5.28	4.50	9.04	4.96	2.91	3.78
PB Ratio	3.81	4.62	6.44	3.38	2.04	4.41
P/TBV Ratio	4.77	9.25	7.22	3.38	2.04	4.41
P/FCF Ratio	13.40	-	18.26	11.76	7.69	11.17
P/OCF Ratio	11.22	12.48	16.68	11.56	7.69	11.16
EV/Sales Ratio	4.52	4.21	7.86	3.75	1.84	3.04
EV/EBITDA Ratio	9.84	13.99	16.33	10.03	5.30	9.75
EV/EBIT Ratio	11.96	19.29	16.53	10.07	5.31	9.77
EV/FCF Ratio	11.06	-	15.88	8.89	4.87	8.99
Debt / Equity Ratio	0.00	0.01	0.01	0.02	0.00	0.01
Debt / EBITDA Ratio	0.02	0.03	0.04	0.08	0.00	0.03
Debt / FCF Ratio	0.02	-	0.04	0.07	0.00	0.03
Asset Turnover	0.78	0.94	0.70	0.65	0.78	1.18
Inventory Turnover	5.08	12.93	7.38	6.20	10.15	33.39
Quick Ratio	4.75	2.51	5.37	7.32	6.45	4.36
Current Ratio	5.11	2.88	5.57	7.76	7.00	4.62
Return on Equity (ROE)	28.29%	20.75%	32.76%	20.98%	58.30%	46.06%
Return on Assets (ROA)	18.35%	12.83%	20.75%	15.22%	16.94%	23.02%
Return on Capital (ROIC)	21.40%	15.60%	24.70%	17.20%	20.00%	28.54%
Earnings Yield	5.67%	3.98%	4.29%	5.66%	21.66%	8.25%
FCF Yield	7.46%	-3.06%	5.48%	8.50%	13.01%	8.95%
Buyback Yield / Dilution	-6.94%	-2.13%	-3.32%	-1.46%	-0.21%	-3.30%
Total Shareholder Return	-6.94%	-2.13%	-3.32%	-1.46%	-0.21%	-3.30%

Source: S&P Capital IQ. Standard template. Financial Sources.